Importantly, the multiple Kaplan-Meier survival analyses suggest that high expression of EZH2 is associated with relapse-free survival [46], indicating that high EZH2 expression correlates with improved survival of CRC patients. This evidence concerns the gene EZH2 and colorectal carcinoma.